Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study
Therapeutic Advances in Respiratory Disease · 2024
DOI: 10.1177/17534666241298794 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2024. Verfasst von Hanbo Pan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Sha…. Hauptthemen laut MEDLINE: COVID-19, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Pneumonectomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Development Center for Medical Science & Technology National Health Commission of the People’s Republic of China, Zhejiang Province Medical and Health Project, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Coronavirus disease (COVID)-19 can lead to chronic lung damage and respiratory issues, potentially increasing surgical difficulty and risk for patients with non-small-cell lung cancer (NSCLC). However, the impacts of a COVID-19 history on early outcomes in NSCLC patients remain controversial.
Objectives
To evaluate the effect of COVID-19 history on early outcomes in NSCLC patients and identify high-risk groups undergoing radical resection based on the largest Chinese multi-center real-world data to date.
Design
Multi-center retrospective cohort study.
Methods
NSCLC patients with (POCVD group) or without (NCVD group) a history of COVID-19 who underwent radical surgery at six institutions from January 2022 to January 2024 were retrospectively reviewed from a prospectively maintained database. Propensity-score matching (PSM) was utilized to minimize patient selection bias.
Results
Out of 7932 cases included, PSM resulted in 3021 cases per group. The two groups were comparable regarding the proportion of male patients (52.0% vs 51.6%) and those aged ⩾70 years (13.3% vs 13.8%). Although the two groups had comparable incidences of complications with Clavien-Dindo grades ⩾II (13.0% vs 14.4%, p = 0.117), the POCVD group had longer surgical durations (120.87 ± 40.23 min vs 110.74 ± 38.76 min, mean difference (95% confidence interval (CI) = 10.13 (8.138–12.122)) and higher rates of respiratory complications than the NCVD group. Subgroup logistic regression analysis indicated that patients aged ⩾70 years (odds ratio (OR) (95% CI) = 1.322 (1.022–1.876)) and those with a smoking history (OR (95% CI) = 1.235 (1.008–1.543)) had an increased risk of developing complications with Clavien-Dindo grades ⩾II. Further analysis confirmed that these high-risk patients experienced extended surgical durations, longer chest tube drainage, and prolonged postoperative hospital stay, along with increased postoperative respiratory complications following COVID-19.
Conclusion
Generally, radical resection is safe for NSCLC patients with a COVID-19 history. However, these patients experienced prolonged surgical durations and a higher incidence of postoperative respiratory complications compared to those without a COVID-19 history. In addition, individuals aged ⩾70 years or with a smoking history faced elevated surgical risks following COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Cardiothoracic Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
- Department of Integrated Traditional Chinese and Western Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
- Department of Cardiothoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Department of Thoracic Surgery, Zhoushan Putuo District People's Hospital, Zhoushan, China.
- Department of Thoracic Surgery, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Jia Huang, Qingquan Luo
Förderung
- Development Center for Medical Science & Technology National Health Commission of the People’s Republic of China
- Zhejiang Province Medical and Health Project
- National Natural Science Foundation of China
- Clinical Scientific Research Program of Wu Jieping Medical Funding
- Shanghai Charity Foundation
- Natural Science Foundation of Ningbo
Zitieren
APA
Pan, H., Chen, H., Li, W., Tian, Y., Ge, Z., Kong, W., Gu, Z., Zou, N., Zhu, H., Zhang, J., Tao, Y., Ning, J., Huang, J., Yin, H., Zhang, M., Zhou, C., Wang, H., Xu, G., & Luo, Q. (2024). Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666241298794
Vancouver
Pan H, Chen H, Li W, Tian Y, Ge Z, Kong W, et al. Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study. Therapeutic Advances in Respiratory Disease. 2024. doi:10.1177/17534666241298794
BibTeX
@article{Pan2024,
author = {Pan, Hanbo and Chen, Hang and Li, Wanyu and Tian, Yu and Ge, Zhen and Kong, Weicheng and Gu, Zenan and Zou, Ningyuan and Zhu, Hongda and Zhang, Jiaqi and Tao, Yixing and Ning, Junwei and Huang, Jia and Yin, Hui and Zhang, Ming and Zhou, Chengwei and Wang, Hui and Xu, Guodong and Luo, Qingquan},
title = {Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
doi = {10.1177/17534666241298794}
}
EUVIMED